Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Satellos Bioscience Inc Com V.ICO


Primary Symbol: ICOTF

iCo Therapeutics Inc is a Canada based biotechnology company. It is involved in the Research and development of ophthalmic indications. The company identifies, develops, and commercialize drug candidates with clinical history, and re-doses, reformulates and develops these drug candidates to treat sight and life-threatening diseases. Its in-licensed assets are iCo-008 and the Oral AmpB Delivery System. iCo-008 is a human monoclonal antibody targeting eotaxin-1 that acts as a messenger between...


GREY:ICOTF - Post by User

Bullboard Posts
Post by zoomzoom3on Jul 12, 2014 2:01pm
181 Views
Post# 22739494

More INSIDER BUYING (CEO) @5.5 Cents

More INSIDER BUYING (CEO) @5.5 Cents
Time to follow the smart money.... If they are willing to throw down more money at these levels signals that ICO is undervalued and poised to head higher. Jul 11/14 Jul 11/14 Rae, Andrew Rae Direct Ownership Common Shares 10 - Acquisition in the public market 150,000 $0.055 Jul 9/14 Jul 9/14 Meekison, William John Direct Ownership Common Shares 10 - Acquisition in the public market 50,000 $0.055
Bullboard Posts